Ketanserin

The Effects of Antihypertensive Therapy on the Quality of Life

1986 • 1,344 citations

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

1986 • 1,255 citations

Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.

1986 • 892 citations

Lipoprotein receptors and cholesterol homeostasis

1983 • 755 citations

Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits.

1986 • 535 citations

Role of endothelium in dilator responses of spontaneously hypertensive rat arteries.

1983 • 414 citations

Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys.

1984 • 375 citations

Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin.

1987 • 303 citations

Review of the role of the central serotonergic neuronal system in blood pressure regulation.

1980 • 249 citations

Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries.

1988 • 187 citations

Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.

1988 • 153 citations

Adenine nucleotides, serotonin, and endothelium-dependent relaxations to platelets

1985 • 143 citations

Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.

1988 • 120 citations

Treatment of raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin₂ (5‐HT₂) receptor

1984 • 116 citations

The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.

1984 • 115 citations

Prevention of atherosclerotic complications: controlled trial of ketanserin. Prevention of Atherosclerotic Complications with Ketanserin Trial Group.

1989 • 104 citations

Evidence for functional 5-HT2 receptor sites on human blood platelets

1984 • 102 citations

Age, race, blood pressure and renin: Predictors for antihypertensive treatment with calcium antagonists

1985 • 100 citations

5-hydroxytryptamine and platelet aggregation.

1983 • 94 citations

Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.

1988 • 89 citations

Potassium Supplementation in Blacks with Mild to Moderate Essential Hypertension

1986 • 88 citations

Comparison of Ketanserin and Sodium Nitroprusside in Patients with Severe ARDS

1988 • 85 citations

Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin.

1982 • 82 citations

Mechanism of antihypertensive action of ketanserin in man.

1983 • 81 citations

Acute effects of the calcium antagonist, nifedipine, on blood pressure, pulse rate, and the renin-angiotensin-aldosterone system in patients with essential hypertension

1982 • 80 citations

Ketanserin in reflex sympathetic dystrophy. A double-blind placebo controlled cross-over trial

1989 • 80 citations

Long-term hemodynamic effects of ketanserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients

1989 • 77 citations

5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.

1984 • 76 citations

Serotonergic Receptor Subtypes and Vascular Reactivity

1984 • 75 citations

Correcting for the bias caused by drop‐outs in hypertension trials

1988 • 74 citations

Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: Possible role of serotonergic mechanisms in portal hypertension

1987 • 71 citations

Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.

1984 • 71 citations

Correcting for the bias caused by dropouts in hypertension trials

1989 • 70 citations

Platelet-vessel wall interactions: Implication of 5-hydroxytryptamine. A review

1984 • 68 citations

Serotonin and the Blood Vessel Wall

1985 • 68 citations

Prolongation of the QT interval as an indicator of risk of a cardiac event

1988 • 67 citations

Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.

1988 • 65 citations

The Pentagastrin Test in the Diagnosis of the Carcinoid Syndrome

1985 • 57 citations

Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist

1984 • 57 citations

International study of ketanserin in Raynaud's phenomenon

1989 • 56 citations

Randomized placebo-controlled, double-blind trial of ketanserin in claudicants. Changes in claudication distance and ankle systolic pressure. PACK Claudication Substudy.

1989 • 51 citations

Pharmacological Control of Platelet and Red Blood Cell Function in the Microcirculation

1981 • 50 citations

Role of Serotonin in Patients with Acute Respiratory Failure

1984 • 50 citations

PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL OF KETANSERIN IN TREATMENT OF INTERMITTENT CLAUDICATION

1984 • 49 citations

Pharmacokinetics of ketanserin in man

1983 • 49 citations

Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension.

1984 • 47 citations

Serotonin and Arterial Vessels

1984 • 45 citations

Cardiopulmonary effects of ketanserin infusion in human pulmonary embolism.

1987 • 42 citations

5-HT2-RECEPTOR BLOCKADE IN THE TREATMENT OF HEART FAILURE

1981 • 42 citations

Ketanserin versus Placebo in Carcinoid Syndrome: A Clinical Controlled Trial

1986 • 39 citations

Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration

1986 • 39 citations

Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets

1983 • 39 citations

Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin

1989 • 39 citations

Ketanserin in essential hypertension: Effects during rest and exercise

1983 • 38 citations

Cardiac Dimensions in Spontaneously Hypertensive Rats Following Different Modes of Blood Pressure Reduction by Antihypertensive Treatment

1986 • 38 citations

THE EFFECT OF KETANSERIN, A SPECIFIC SEROTONIN ANTAGONIST ON THE PRL, GH, ACTH AND CORTISOL RESPONSES TO HYPOGLYCAEMIA IN NORMAL SUBJECTS

1984 • 37 citations

Antihypertensive Action and Serotonin-Induced Platelet Aggregation During Long-Term Ketanserin Treatment in Hypertensive Patients

1984 • 36 citations

The Acute Antihypertensive Effect of Ketanserin Increases with Age

1985 • 35 citations

Pharmacokinetics and Pharmacodynamics of the 5-HT2 Receptor Antagonist Ketanserin in Man

1983 • 35 citations

Chronic effect of ketanserin in mild to moderate essential hypertension.

1986 • 35 citations

Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study.

1988 • 35 citations

The Use of Ketanserin, a 5-Hydroxytryptamine Receptor Antagonist, for Treatment of Postoperative Hypertension Following Coronary Artery Bypass Surgery

1983 • 35 citations

Use of topical ketanserin in the treatment of skin ulcers: A double-blind study

1989 • 34 citations

Regional vascular effects of serotonin and ketanserin in young, healthy subjects.

1988 • 33 citations

Effect of the Serotonin Antagonist Ketanserin on the Hemodynamic and Morphological Consequences of Thrombotic Infarction

1989 • 32 citations

Acute hemodynamic effects of ketanserin in pulmonary hypertension secondary to systemic sclerosis.

1987 • 29 citations

Ketanserin in essential hypertension: a double-blind, placebo-controlled study

1985 • 29 citations

Selective antagonism of S2-serotonergic receptors relieves but does not prevent cold induced vasoconstriction in primary Raynaud's phenomenon.

1986 • 29 citations

High-performance liquid chromatographic assay with fluorometric detection of ketanserin, a new antihypertensive agent and serotonin S2 antagonist in human plasma, blood and urine

1983 • 28 citations

Hypertension in the Elderly

1988 • 28 citations

PLACEBO-CONTROLLED, DOUBLE-BLIND, TWO-CENTRE TRIAL OF KETANSERIN IN INTERMITTENT CLAUDICATION

1985 • 27 citations

Cooling Augments Platelet-Induced Contraction of Peripheral Arteries of the Dog

1984 • 26 citations

Acute hemodynamic response to the S2-serotonergic receptor antagonist, ketanserin, in patients with primary pulmonary hypertension

1987 • 26 citations

Effects of Ketanserin on Peripheral Blood Flow, Haemorheology, and Platelet Function in Patients with Raynaudʼs Phenomenon

1985 • 26 citations

Effect of the 5‐hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin‐angiotensin system and sympatho‐adrenal function in patients with essential hypertension.

1984 • 25 citations

Methods of Assessing the Effect of Drug Therapy on Quality of Life

1990 • 25 citations

Controlled trial of ketanserin in hypertension.

1985 • 25 citations

Serotonin and the Flow Properties of Blood

1985 • 24 citations

Coronary Atherosclerosis and Plasma Lipoproteins

1982 • 24 citations

Intrapartum treatment of preeclamptic hypertension by ketanserin

1986 • 24 citations

Carcinoid syndrome and serotonin: Therapeutic effects of ketanserin

1990 • 24 citations

Ketanserin, A Serotonin Antagonist

1984 • 24 citations

Ketanserin in the treatment of systemic sclerosis: a double-blind controlled trial

2006 • 24 citations

EFFECTS OF URAPIDIL, KETANSERIN AND SODIUM NITROPRUSSIDE ON VENOUS ADMIXTURE AND ARTERIAL OXYGENATION FOLLOWING CORONARY ARTERY BYPASS GRAFTING

1990 • 24 citations

Chronic 5-HT2 receptor blockade with ritanserin does not reduce blood pressure in the spontaneously hypertensive rat

1985 • 23 citations

A Comparative and Long-Term Evaluation of Ketanserin in the Treatment of Essential Hypertension

1985 • 23 citations

Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.

1985 • 23 citations

Ketanserin Versus α-Methyldopa in the Treatment of Hypertension During Pregnancy

1987 • 22 citations

STUDIES ON THE MECHANISM OF ACTION OF THE HYPOTENSIVE EFFECT OF KETANSERIN

1984 • 22 citations

Ketanserin in Intermittent Claudication

1987 • 22 citations

The role of serotonin (5-HT) in the control of TSH and prolactin release in euthyroid subjects as assessed by the administration of ketanserin (5-HT2 antagonist) and zimelidine (5-HT re-uptake inhibitor)

1984 • 22 citations

Effect of Ketanserin in Primary Aldosteronism

1985 • 22 citations

The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases

1985 • 21 citations

Ketanserin in the Preoperative and Intraoperative Management of a Patient with Carcinoid Tumor Undergoing Tricuspid Valve Replacement

1986 • 21 citations

Pharmacokinetic approach to equilibrium between ketanserin and ketanserin-ol

1986 • 20 citations

Chronic leg ulceration with livedoid vasculitis, and response to oral ketanserin

1989 • 20 citations

Pathogenesis and treatment of Raynaud's phenomenon

1990 • 20 citations

Bioavailability and pharmacokinetics of ketanserin in elderly subjects

1985 • 20 citations

Cardiac Electrophysiologic Effects of Intravenous Ketanserin in Humans

1987 • 19 citations

Pharmacokinetics of ketanserin in patients with essential hypertension

1987 • 19 citations

Ketanserin treatment and serotonin in patients with primary and secondary Raynaud's phenomenon

1988 • 19 citations

Converting Enzyme Inhibitors in the Treatment of Hypertension

1987 • 18 citations

Effects of Ketanserin on Platelet Function and Red Cell Filterability in Hypertension and Peripheral Vascular Disease

1985 • 18 citations

The effect of a 5‐HT antagonist, ketanserin, on blood pressure, the renin‐angiotensin system and sympathoadrenal function in normal man.

1983 • 18 citations

Continuous Inhibition of Platelet S2-Serotonergic Receptors During Chronic Administration of Ketanserin in Humans

1985 • 18 citations

Interaction Between S2-Serotonergic and α1-Adrenergic Receptor Activities at Vascular Sites

1988 • 18 citations

Arterial and Venous Effects of Serotonin in the Forearm of Healthy Subjects Are Not Age-Related

1989 • 17 citations

Double-Blind Placebo-Controlled Study with Topical 2% Ketanserin Ointment in the Treatment of Venous Ulcers

1989 • 17 citations

Cardiovascular Effects of Ketanserin in the Treatment of Hypertension During Coronary Artery Bypass Surgery

1986 • 17 citations

Effect of ketanserin in the treatment of patients with intermittent claudication: results from 13 placebo-controlled parallel group studies.

1987 • 17 citations

The α-Adrenergic Receptor Blocking Effect of Ketanserin and the Interaction Between α-Adrenergic and S2-Serotonergic Receptor Blockade

1988 • 17 citations

Responses of the Systemic Circulation and of the Renin—Angiotensin—Aldosterone System to Ketanserin at Rest and Exercise in Normal Man

1984 • 17 citations

5-HT2-Receptor Antagonists

1988 • 16 citations

Peri?operative management of carcinoid syndrome using ketanserin

1986 • 16 citations

Age-Related Effects of Angiotensin Converting Enzyme Inhibitors

1988 • 16 citations

Long-term Effects on Central Haemodynamics and Body Fluid Volumes of Ketanserin in Essential Hypertension Studies at Rest and during Dynamic Exercise

1983 • 16 citations

Blood Pressure, 5-OH Indoleacetic Acid, and Vanilmandelic Acid Excretion and Blood Platelet Aggregation in Hypertensive Patients Treated with Ketanserin

1985 • 16 citations

Placebo-Controlled Trial of Ketanserin in the Treatment of Intermittent Claudication

1987 • 15 citations

Double-blind comparison of ketanserin with atenolol: antihypertensive activity and effect on platelet function.

1986 • 15 citations

Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.

1984 • 15 citations

Controlled Comparison of Ketanserin and Nifedipine in Raynaud's Phenomenon

1989 • 15 citations

Blood pressure reduction and pharmacokinetics of ketanserin in hypertensive patients.

1986 • 15 citations

Ketanserin and α1-Adrenergic Antagonism in Humans

1985 • 15 citations

Acute and chronic ketanserin in essential hypertension: antihypertensive mechanisms and pharmacokinetics.

1987 • 15 citations

EFFECT OF KETANSERIN ON SODIUM NITROPRUSSIDE REQUIREMENTS, ARTERIAL PRESSURE CONTROL AND HEART RATE FOLLOWING CORONARY ARTERY BYPASS SURGERY

1989 • 14 citations

Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta‐adrenoceptor antagonist.

1987 • 14 citations

Cardiac Electrophysiologic Effects of Intravenous Ketanserin in Humans

1987 • 14 citations

Comparison of Ketanserin and Metoprolol in the Treatment of Essential Hypertension

1987 • 14 citations

Effects of intra-arterial ketanserin in Raynaud's phenomenon assessed by 99MTc-pertechnetate scintigraphy

1988 • 13 citations

Age-Related Effects of Antihypertensive Therapy with α-Blockers

1988 • 13 citations

Serotonin antagonists and vascular protection

1990 • 13 citations

Ketanserin in the Acute Management of Severe Hypertension

1985 • 13 citations

Pharmacodynamics and pharmacokinetics of single doses of ketanserin and propranolol alone and in combination in healthy volunteers.

1986 • 12 citations

Inhibition of cold-induced vasoconstriction with ketanserin

1985 • 12 citations

Effects of ketanserin of left ventricular hypertrophy in hypertensive patients

1990 • 12 citations

Ketanserin and prazosin: A comparison of antihypertensive and biochemical effects

1986 • 12 citations

Therapeutic Efficacy of Ketanserin, a Selective Antagonist of the Serotonin (5-HT 2) Receptors, in Primary and Secondary Raynaud's Phenomenon

1987 • 12 citations

Effect of the 5-HT2 antagonist ketanserin on the ECT-induced prolactin release

1989 • 12 citations

Ketanserin in the treatment of Raynaud's phenomenon associated with generalized scleroderma

1988 • 11 citations

Effects of Ketanserin on Blood Pressure and Platelet Aggregation in Elderly Men with Mild Hypertension

1988 • 11 citations

Ketanserin and the arterial baroreceptor reflex in normotensive subjects

1987 • 11 citations

The effectiveness of ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled study.

1987 • 11 citations

The Use of Hemorheological and Microcirculatory Parameters in Evaluating the Effect of Treatment in Raynaud's Phenomenon

1987 • 11 citations

Age-Related Effects of Converting Enzyme Inhibitors

1988 • 11 citations

Antihypertensive Efficacy of Ketanserin Alone or in Combination with a β-Blocker or a Diuretic

1987 • 10 citations

A comparative study of ketanserin and metoprolol in essential hypertension.

1986 • 10 citations

Ketanserin in the treatment of pulmonary hypertension after valvular surgery

1989 • 10 citations

α-Adrenergic blockade makes minimal contribution to ketanserin's hypotensive effect

1988 • 10 citations

Effect of Ketanserin on Hemodynamics, Plasma-Catecholamine Concentrations, and Serotonin Uptake by Platelets in Volunteers and Patients with Congestive Heart Failure

1985 • 10 citations

Plasma protein binding of ketanserin and its distribution in blood.

1988 • 10 citations

Ketanserin Versus Nifedipine in the Treatment of Essential Hypertension in Patients Over 50 Years Old

1987 • 10 citations

Ketanserin concentration‐effect relationships in individual hypertensive patients.

1988 • 10 citations

Nitroprusside and ketanserin in the treatment of postoperative hypertension following coronary artery bypass grafting: a haemodynamic and ventilatory comparison.

1986 • 10 citations

Correction by ketanserin of the platelet‐mediated inhibition of peripheral collateral circulation in the cat: Measurement of blood flow with radioactive microspheres

1986 • 10 citations

Renal effects of ketanserin in essential hypertension.

1986 • 10 citations

Age-Related Effects of Diuretics in Hypertensive Subjects

1988 • 10 citations

Prolongation of the QT interval by ketanserin

1988 • 10 citations

Antihypertensive Mode of Action of Ketanserin

1987 • 9 citations

Acute Effects and Mechanism of Action of Ketanserin in Patients with Primary Raynaudʼs Phenomenon

1990 • 9 citations

Studies on Alpha2-Adrenoceptors in Rabbits with Perinephritis Hypertension

1986 • 9 citations

Experience with Ketanserin and Ritanserin in Hypertensive Patients

1988 • 9 citations

Statistical Pitfalls in the Analysis of Age-Related Effects in Antihypertensive Therapy

1988 • 9 citations

Serum Cholesterol During Ketanserin and Propranolol Administration in Hypertensive Patients

1987 • 9 citations

Antihypertensive Mechanism of Ketanserin in Postoperative Hypertension After Cardiopulmonary Bypass

1988 • 9 citations

The effectiveness of ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled study.

1987 • 9 citations

Comparison of Blood Pressure Ratio by Doppler Velocimetry and by Plethysmography During Treatment with Ketanserin, a 5-HT2 Receptor Antagonist

1985 • 9 citations

Ketanserin versus nifedipine in secondary Raynaud's phenomenon.

1987 • 9 citations

The use of the selective serotonin S2 receptor antagonist Ketanserin in the treatment of Raynaud's phenomenon

1988 • 9 citations

Ketanserin pharmacokinetics in patients with renal failure.

1990 • 9 citations

Effects of Intravenous Ketanserin on Severely Hypertensive Patients with Double-Blind Crossover Assessment of Central Side-Effects

1987 • 8 citations

Could the increased antihypertensive efficacy of ketanserin in the elderly be due to altered pharmacokinetics?

1990 • 8 citations

Age-related effects of beta-blockers and hypertension.

1988 • 8 citations

Hyperreactivity of Platelets to Serotonin (5-Hydroxytryptamine) in Patients with Cardiovascular Diseases

1988 • 8 citations

Study with the Competitive 5-HT2-Serotonergic Antagonist Ketanserin

1985 • 8 citations

Treatment of arterial hypertension with ketanserin in mono- and combination therapy

1985 • 8 citations

Why Are the Antihypertensive Effects of Ketanserin Age-Related?

1988 • 8 citations

Retrospective Analyses for Hypothesis Generation A Commentary on the Pack Trial (Prevention of Atherosclerotic Complications with Ketanserin)

1989 • 8 citations

Absorption, metabolism and excretion of ketanserin in man after oral administration.

1988 • 8 citations

Pharmacokinetics of Ketanserin in Patients with Cirrhosis

1990 • 7 citations

Moderate essential hypertension control: a double-blind crossover study between a serotonin antagonist and a post-synaptic alpha-blocker.

1986 • 7 citations

Ketanserin versus metoprolol in the treatment of essential hypertension.

1986 • 7 citations

Left ventricular hypertrophy regression and function changes with ketanserin in elderly hypertensives

1990 • 7 citations

The pharmacokinetics of ketanserin after a single dose and at steady-state in hypertensive subjects

1987 • 7 citations

Is There α-Adrenergic Blockade and/or Serotonergic Blockade During Chronic Ketanserin Treatment?

1985 • 7 citations

Clinical experience with ketanserin in the treatment of hypertension.

1986 • 7 citations

Effect of Ketanserin, a New Inhibitor of 5-HT<sub>2</sub> Receptors, on Plasma Renin Activity and Aldosterone Levels in Normal Subjects

1982 • 7 citations

Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.

1986 • 7 citations

Comparison of ketanserin and slow‐release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta‐adrenoceptor blocker.

1987 • 7 citations

Cold Hands after Exposure to Arsenic or Vibrating Tools: Effects of Ketanserin on Finger Blood Pressure and Skin Temperature

1986 • 7 citations

Renal Hemodynamic Effects of Ketanserin Therapy in Essential Hypertension

1987 • 6 citations

Effect of Ketanserin, an Inhibitor of 5-HT<sub>2</sub> Receptors, on the Aldosterone-Stimulating Action of Metoclopramide

1983 • 6 citations

Comparison of ketanserin and enalapril in the treatment of mild-to-moderate essential hypertension

1990 • 6 citations

Serotonergic Blockade Compared with Beta‐Adrenergic Blockade in Systemic Hypertension: A Double‐Blind Comparison of Ketanserin with Propranolol

1988 • 6 citations

Comparison of Ketanserin with Captopril in Older Hypertensives

1988 • 6 citations

Effect of Ketanserin on the Kinetics of Digoxin and Digitoxin

1985 • 6 citations

A placebo-controlled crossover study of ketanserin in elderly hypertensive patients

1990 • 6 citations

Age Dependency of Blood Pressure Response to Antihypertensive Treatment

1988 • 6 citations

Haemorheological effects of ketanserin, a selective 5-HT2 receptor antagonist, in aged, spontaneously hypertensive dogs.

1982 • 6 citations

Effects of ketanserin on microhemodynamics and hemorheology in patients with essential hypertension

1990 • 6 citations

Serotonin Metabolism and Age-Related Effects of Antihypertensive Therapy with Ketanserin

1988 • 6 citations

Effects of ketanserin on ambulatory blood pressure monitoring in patients with essential hypertension.

1986 • 6 citations

The Effect of Ketanserin on Blood Pressure and Platelets during Cardiopulmonary Bypass

1987 • 6 citations

[Ketanserin versus sodium nitroprusside in the treatment of hypertension following coronary surgery. Effect on intrapulmonary right and left shunt and arterial oxygenation].

1989 • 6 citations

Platelet function during long-term treatment with ketanserin of claudicating patients with peripheral atherosclerosis. A multi-center, double-blind, placebo-controlled trial

1989 • 6 citations

Alpha 1-adrenoceptor responsiveness: the influence of age.

1988 • 6 citations

Ketanserin in the Treatment of Progressive Systemic Sclerosis

1988 • 6 citations

[Treatment of systemic scleroderma with ketanserin. Randomized, double-blind 6-months study of 27 cases].

1986 • 6 citations

Double-Blind Comparison of Ketanserin and Propranolol in Hypertensive Patients

1988 • 5 citations

Effects of ketanserin tartrate on 3-hydroxy, 3-methylglutaryl coenzyme a reductase activity in cultured human skin fibroblasts

1990 • 5 citations

Sublingual and intravenous ketanserin versus sublingual nifedipine in the treatment of severe hypertension: a randomized study.

1989 • 5 citations

Long-term safety and efficacy of ketanserin in essential hypertension: ketanserin versus or in combination with metoprolol.

1986 • 5 citations

Mechanism of action of ketanserin in hypertension and vasospastic disease.

1987 • 5 citations

Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.

1987 • 5 citations

Are There Reasons to Believe That the Antihypertensive Effects of Serotonin (S2) Antagonists Are Age-Related?

1988 • 5 citations

Ketanserin and the cardiovascular system

1986 • 5 citations

Ketanserin and captopril interaction in the treatment of essential hypertensives

1990 • 5 citations

Influence of ketanserin pretreatment on the haemodynamic responses to sternotomy

1986 • 5 citations

Effect of intravenous ketanserin on plasma catecholamines and renin activity in normal volunteers

1985 • 5 citations

Continuous Inhibition of Serotonin-Induced Platelet Aggregation during Chronic Ketanserin Administration to Man Can Be Detected after Plasma pH Control

1987 • 5 citations

The effects of serotonin-receptor blockade after cardiopulmonary by-pass. A pilot study.

1982 • 5 citations

Age and efficacy of calcium entry blocker in essential hypertension. Double blind trial using nicardipine.

1986 • 5 citations

Ketanserin in the Treatment of Systemic Hypertension During and Following Coronary Artery Bypass Surgery

1989 • 5 citations

Ketanserin in the treatment of mild hypertension in elderly patients: preliminary results of a controlled double-blind trial.

1986 • 5 citations

Antihypertensive efficacy and well-being during monotherapy and combination therapy with ketanserin

1989 • 4 citations

Cold-induced Raynaud's phenomenon ameliorated by intravenous administration of ketanserin: a double-blind cross-over study

1986 • 4 citations

Interpreting age-related aspects of antihypertensive treatment: statistical defects and their remedy.

1988 • 4 citations

Ketanserin and the cardiovascular response to intubation: a preliminary report.

1987 • 4 citations

Mechanism of action of ketanserin: studies on cardiovascular reactivity in essential and diabetes-associated hypertension

1988 • 4 citations

Double-Blind Comparison of Ketanserin with Placebo in Patients with Essential Hypertension

1986 • 4 citations

Cardiovascular effects of ketanserin during cold pressure and during isometric and dynamic exercise in hypertensive patients.

1987 • 4 citations

Lack of effect of propranolol on the steady-state plasma levels of ketanserin.

1985 • 4 citations

Regression of left ventricular hypertrophy and systolic function in hypertensive patients during long-term treatment with ketanserin

1990 • 4 citations

Blood pressure during a combination of ketanserin and hydrochlorothiazide.

1987 • 4 citations

Profound hypotension after the first dose of ketanserin

1987 • 4 citations

Evidence for a direct and non-receptor-mediated action of 5HT2 antagonists on transmembrane cation transport systems

1990 • 4 citations

Effects of short‐term ketanserin treatment on the QT interval and vagal function in healthy subjects

1989 • 4 citations

A comparative study of ketanserin and metoprolol in essential hypertension.

1985 • 4 citations

Intra Arterial Ketanserin in Peripheral Vascular Disease

1986 • 4 citations

Effects of Ketanserin Tartrate on Serum Lipids in Patients with Essential Hypertension

1988 • 4 citations

EFFECTS OF KETANSERIN ON CARDIOVASCULAR, SYMPATHO‐ADRENAL AND ENDOCRINE SYSTEMS DURING PHYSICAL EXERCISE IN MAN

1987 • 4 citations

Hypertensive Patients with Raynaudʼs Phenomenon or Intermittent Claudication and Their Treatment with Ketanserin

1988 • 3 citations

Antihypertensive and metabolic effects of ketanserin in diabetic patients with mild hypertension.

1988 • 3 citations

Effect of intravenous ketanserin on the human action potential duration at fixed heart rate

1988 • 3 citations

Effects of Ketanserin on Systemic and Regional Haemodynamics in Patients with Essential Hypertension

1988 • 3 citations

Lack of effect of ketanserin on indices of hepatic enzyme induction.

1987 • 3 citations

Effect of ketanserin and prazosin on blood pressure and cardiovascular reactivity to vasopressor agents during the development of two kidney - two clip renal hypertension in the conscious rat

1989 • 3 citations

Ketanserin in the treatment of hypertension following coronary artery bypass surgery. A preliminary study.

1983 • 3 citations

Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.

1988 • 3 citations

The effects of ketanserin on ventricular ectopic activity in humans

1990 • 3 citations

The interactions of propranolol and ketanserin

1987 • 3 citations

Ketanserin (S2-receptor blocking agent), platelet activity and chronic alcoholism.

1986 • 3 citations

Ketanserin and Metoprolol in Essential Hypertension

1985 • 3 citations

Effect of Ketanserin on Lipoproteins in Patients with Essential Hypertension

1988 • 2 citations

Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.

1986 • 2 citations

A double-blind comparative study of ketanserin with atenolol in essential hypertension.

1989 • 2 citations

Plasma concentrations of ketanserin in chronic hemodialysed patients.

1986 • 2 citations

Oral dosing with ketanserin to control high blood pressure in the elderly

1990 • 2 citations

Ketanserin combined with a beta-blocker or diuretic in essential hypertension. A multicentre study

1988 • 2 citations

Effects of Ketanserin on Lipids, Lipoproteins, and Plasma Atrial Natriuretic Factor in Patients with Essential Hypertension

1990 • 2 citations

Comparative Study of Ketanserin and Hydrochlorothiazide in Essential Hypertension

1988 • 2 citations

Haemodynamic Changes Associated with Long Term Antihypertensive Therapy with Ketanserin

1988 • 1 citations

Effect of ketanserin on macrocirculatory and microcirculatory blood flow in patients with intermittent claudication. A prospective randomized study

1989 • 1 citations

An evaluation of ketanserin therapy for the hypertensive diabetic patient

1989 • 1 citations

[Blood pressure lowering action and tolerance of ketanserin in mono- or combination therapy].

1989 • 1 citations

Influence of Ketanserin on Glucose and Lipid Metabolism in Diabetic Patients with Hypertension

1988 • 1 citations

Ketanserin in the Treatment of Essential Hypertension a Double Blind Trial Against Metoprolol Followed By One-year open Treatment

1989 • 1 citations

[Prolonged treatment with ketanserin in essential hypertension and comparison with metoprolol].

1985 • 1 citations

Antihypertensive Therapy with Ketanserin

1988 • 1 citations

Serotonin antagonism reduces the adverse symptoms of beta blockade

1990 • 1 citations

Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.

1989 • 1 citations

Antihypertensive therapy with ketanserin: effects on central and renal hemodynamics, and microalbuminuria.

1990 • 1 citations